Clinical Trial Update: Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immune lot consistency, immunogenicity, and safety of an investigational quadrivalent meningococcal conjugate vaccine; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Diseases
• Meningococcal Infections

Drugs mentioned

• Investigational quadrivalent meningococcal conjugate vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2020-03-09